$175.00
Clinical Results: In clinical trials (SURMOUNT-OSA), nearly 50% of participants saw their sleep apnea resolve to the point where they no longer required a CPAP machine or met the criteria for the disorder.
buy Tirzepatide in UK is a groundbreaking medication that represents a new class of drugs known as dual GIP and GLP-1 receptor agonists.
In December 2024, the FDA officially expanded its approved uses to include Obstructive Sleep Apnea (OSA), making it the first medication of its kind approved to treat the underlying cause of this condition in adults with obesity.
The medication is marketed under two different names depending on the primary reason for the prescription:
Mounjaro: Prescribed for the treatment of Type 2 Diabetes.
Zepbound: Prescribed for Chronic Weight Management (obesity) and Obstructive Sleep Apnea (OSA).
Unlike older medications like Ozempic (which only targets the GLP-1 hormone), tirzepatide mimics two naturally occurring gut hormones. This dual action is often more effective for weight loss and blood sugar control.
GLP-1 (Glucagon-like peptide-1):
Slows down stomach emptying (making you feel full longer).
Signals the brain to reduce hunger and “food noise.”
Triggers the pancreas to release insulin only when blood sugar is high.
GIP (Glucose-dependent insulinotropic polypeptide):
Works alongside GLP-1 to further improve insulin secretion.
Is believed to enhance how the body breaks down fat and manages energy.
May help reduce the nausea often associated with GLP-1-only drugs.
For patients with obesity, OSA is often caused by excess tissue in the throat that collapses during sleep. Tirzepatide treats this by:
Reducing Airway Obstruction: Significant weight loss reduces the physical pressure on the airway.
Clinical Results: In clinical trials (SURMOUNT-OSA), nearly 50% of participants saw their sleep apnea resolve to the point where they no longer required a CPAP machine or met the criteria for the disorder.
Administration: It is a once-weekly subcutaneous injection (under the skin).
Common Side Effects: Mostly gastrointestinal, including nausea, diarrhea, constipation, and stomach pain. These usually improve as the body adjusts to the dose.
Serious Risks: It carries a boxed warning regarding thyroid C-cell tumors (based on animal studies) and should not be used by individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC).
[!IMPORTANT] Contraception Note: Tirzepatide can affect the absorption of oral contraceptives. Doctors often recommend switching to a non-oral method or adding a barrier method for 4 weeks after starting the drug or increasing the dose.
Would you like me to look into the specific dosage titration schedule or compare its weight loss results to other medications like semaglutide?
